NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $6,000 | -99.0% | 1,310 | -98.9% | 0.00% | -100.0% |
| Q2 2014 | $599,000 | -9.2% | 120,913 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $660,000 | -10.1% | 120,913 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $734,000 | +42.2% | 120,913 | +55.2% | 0.00% | +50.0% |
| Q3 2013 | $516,000 | – | 77,899 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 39,100 | $213,000 | 0.16% |
| Eidelman Virant Capital | 26,796 | $146,000 | 0.07% |
| WMS Partners, LLC | 63,350 | $346,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 62,742 | $342,000 | 0.04% |
| Brown Advisory Securities, LLC | 11,000 | $60,000 | 0.02% |
| CROFT-LEOMINSTER INC | 20,000 | $109,000 | 0.02% |
| Advisors Asset Management, Inc. | 77,065 | $600,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $136,000 | 0.01% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 3,008 | $16,000 | 0.00% |
| CANADA PENSION PLAN INVESTMENT BOARD | 120,913 | $660,000 | 0.00% |